Metabolic Health
New Skincare Protocol Combats GLP-1 Weight Loss Drug Side Effects on Facial Aging
Flavo-Proxylane topical treatment plus ultrasound reduced skin laxity by 44% in people using weight loss medications.
Research Paper
Mar 28, 2026 3
Results for "Fibermaxxing" in Diabetes
20 articles
Metabolic Health
PEMF Therapy Boosts Mitochondrial ATP Synthesis Without Affecting Uncoupled Respiration
New research reveals pulsed electromagnetic field therapy selectively enhances ATP-linked mitochondrial respiration, pointing to a specific cellular energy mechanism.
Research Paper
Apr 22, 2026 0
Metabolic Health
New Protein Target MOXD1 Opens Door to Treating Fatty Liver Disease
Scientists identify MOXD1 as a driver of MASH and show blocking it with a small molecule reverses liver fat accumulation in mice.
Research Paper
May 22, 2026 0
Metabolic Health
EDP-305 Targets NASH in Phase 2 Trial Testing Two Doses Against Placebo
Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.
Clinical Trial
Jun 18, 2026 0
Metabolic Health
Max Lugavere Reveals One Simple Tip to Accelerate Fat Loss
Popular health educator Max Lugavere shares a straightforward strategy to boost fat burning and optimize body composition.
Video
Apr 2, 2026 0
Metabolic Health
16-Hour Overnight Fast Boosts Muscle Protein Building in Small University Study
New research suggests extending overnight fasting from 10 to 16 hours may enhance muscle's ability to use dietary protein for growth.
Clinical Trial
Mar 29, 2026 1
Metabolic Health
Smart Hydrogel Plus Stem Cell Exosomes Accelerate Diabetic Wound Healing
A dual-action therapy combining a glucose-responsive hydrogel with stem cell exosomes dramatically speeds diabetic wound closure in mice.
Research Paper
Apr 23, 2026 0
Metabolic Health
Premium
AMPK at the Cutting Edge: Isoforms, Substrates, and Therapeutic Frontiers
Master the advanced molecular architecture of AMPK — from isoform-specific signaling and spatial compartmentalization to emerging pharmacological strategies targeting the energy sensor at the heart of longevity biology.
TutorialAdvanced
May 10, 2026 0
Metabolic Health
Magnetic Field Pulses Boost Embryonic Muscle Development in Just 10 Minutes a Week
Brief weekly PEMF exposures increased quail embryo weight by ~20%, body length by ~15%, and upregulated key oxidative muscle genes.
Research Paper
Apr 24, 2026 0
Metabolic Health
Smart Biomaterials Use Electricity and Magnetism to Heal Diabetic Wounds
Electromagnetic biomaterials offer breakthrough approach to diabetic wound healing by reducing inflammation and promoting tissue regeneration.
Research Paper
Apr 4, 2026 0
Metabolic Health
New Oral Weight Loss Drug Shows 6kg Reduction in 28-Day Chinese Study
HDM1002, an oral GLP-1 receptor agonist, achieved significant weight loss with manageable side effects in overweight Chinese adults.
Research Paper
Mar 28, 2026 2
Metabolic Health
Erratum: Mechanosensitive Bone Marrow Lipolytic Factor Linked to Osteogenesis and Lymphopoiesis (2022 Paper)
An erratum to a 2022 Cell Metabolism paper describing a bone marrow lipolytic factor that links mechanical force to bone formation and lymphocyte production.
Research Paper
Jun 19, 2026 0
Metabolic Health
MASH Treatment Revolution: Semaglutide, Tirzepatide Lead a New Drug Era
A landmark JCI review maps the expanding pharmacological arsenal for MASH, from GLP-1 agonists to triple receptor therapies and precision medicine.
Research Paper
May 30, 2026 0
Metabolic Health
New Protein Target Could Unlock FGF21's Power Against Fatty Liver Disease
Scientists discover how FGF21 fights liver disease through a key protein, opening new treatment paths for metabolic dysfunction.
Research Paper
Apr 3, 2026 0
Metabolic Health
New Drug GFT505 Shows Promise for Fatty Liver Disease in Phase IIb Trial
275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.
Clinical Trial
Mar 28, 2026 2
Metabolic Health
FDA Fast-Tracks New Weight Loss Drug Foundayo Under Priority Program
Orforglipron approved 294 days ahead of schedule for obesity treatment, marking first drug under new priority voucher system.
Drug Approval
Apr 16, 2026 0
Metabolic Health
Metformin Plus Strength Training Shows Promise for Muscle Building in Seniors
Clinical trial tested whether metformin could enhance resistance training benefits for muscle mass and strength in older adults.
Clinical Trial
Mar 28, 2026 1
Metabolic Health
Orforglipron Oral GLP-1 Pill Approved as Obesity Pipeline Heats Up
The FDA reportedly approved Eli Lilly's orforglipron, a daily oral GLP-1 receptor agonist for obesity, marking a potential shift from injectable weight-loss drugs.
Drug Approval
Apr 21, 2026 0
Metabolic Health
GLP-1 Drugs Work Better When Paired With Exercise and Nutrition Support
A new review argues that combining GLP-1 receptor agonists with structured exercise and dietary support preserves muscle and delivers lasting fat loss.
Review
Jun 28, 2026 0
Metabolic Health
FDA Approves Foundayo for Weight Loss in Record 50 Days
New GLP-1 drug Foundayo gets fastest FDA approval since 2002, targeting obesity and metabolic health through appetite control.
Drug Approval
Apr 6, 2026 0
Page 1 of 2Next